神经发育障碍中的NMDA受体:病理生理学和疾病模型
Roshan Tumdam1, Yara Hussein1, Tali Garin-Shkolnik2
1Sagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa 3103301, Israel.
N-甲基-D-酸盐受体 (NMDARs),特别是GRIN2子单元,对于大脑发育和功能至关重要. 它们的功能障碍与神经发育障碍有关,因此需要进一步研究针对性疗法.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- N-甲基-D-酸盐受体 (NMDARs) 对中枢神经系统功能,如突触传输和神经发育至关重要.
- NMDARs的GRIN2子单元 (GluN2A-D) 通过替代拼接和遗传变异表现出多样性,影响受体活性和定位.
- GRIN2子单元的适当时间和空间表达对神经发育至关重要,与神经发育障碍 (NDD) 相关的干扰.
研究的目的:
- 审查NMDAR的结构和功能特征,重点关注GRIN2子单位.
- 探索GRIN2子单元的生理特性和发育调节.
- 突出NMDAR功能障碍在NDD病理生理学的作用,并讨论当前的研究方法.
主要方法:
- 对NMDAR结构,功能和遗传学现有文献的审查.
- 分析GRIN2亚单元多样性对受体特性和疾病的影响.
- 检查实验模型,包括小鼠模型和人类诱导的多能干细胞 (hiPSCs),以研究NDDs中的NMDARs.
主要成果:
- GRIN2亚单元的多样性显著影响NMDAR功能,突触集成和疾病结果.
- GRIN2子单元的发育失调与神经发育障碍有关,例如自闭症谱系障碍,和精神分裂症.
- 了解NMDAR亚单元组成和突变是开发NDD治疗策略的关键.
结论:
- NMDARs,特别是它们的GRIN2子单元,在正常的大脑发育和功能中起着至关重要的作用.
- 在NMDAR亚单元表达和功能的改变是各种神经发育障碍的病理生理学的核心.
- 对NMDAR的进一步研究为NDD的新型治疗干预提供了有希望的途径.
更多相关视频
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
06:34Author Spotlight: A Lightweight Drive Implant for Chronic Tetrode Recordings in Juvenile Mice
Published on: June 2, 2023
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
